Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
War in Ukraine: Impacts on the Polish cancer care system and vaccination challen...
Prof Piotr Rutkowski
War in Ukraine: Impacts on the Polish cancer care system and vaccination challenges ( Prof Piotr Rutkowski )
4 May 2022
War in Ukraine: Current and future impacts on the Romanian cancer care system
Dr Nicoleta Antone
War in Ukraine: Current and future impacts on the Romanian cancer care system ( Dr Nicoleta Antone )
29 Apr 2022
Lymphoma Coalition: Challenges for Ukrainian haematological cancer patients
Prof Natacha Bolaños
Lymphoma Coalition: Challenges for Ukrainian haematological cancer patients ( Prof Natacha Bolaños )
28 Apr 2022
Natural killer cells complexed with a bispecific antibody may provide new treatm...
Prof Yago Nieto - The University of Texas MD Anderson Cancer Center, Houston, US...
Natural killer cells complexed with a bispecific antibody may provide new treatment option for patients with advanced lymphoma ( Prof Yago Nieto - The University of Texas MD Anderson Cancer Center, Houston, USA )
26 Apr 2022
Intratumoral BO-112 with pembrolizumab shows benefit in advanced melanoma refrac...
Dr Iván Márquez-Rodas - Hospital General Universitario Gregorio Marañón, Madrid,...
Intratumoral BO-112 with pembrolizumab shows benefit in advanced melanoma refractory to anti-PD-1 therapy ( Dr Iván Márquez-Rodas - Hospital General Universitario Gregorio Marañón, Madrid, Spain )
21 Apr 2022
Novel bispecific checkpoint inhibitor MEDI5752 shows promise for advanced solid ...
Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia
Novel bispecific checkpoint inhibitor MEDI5752 shows promise for advanced solid tumours ( Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia )
14 Apr 2022
Immune gene signatures for predicting response to neoadjuvant chemoimmunotherapy...
Dr Marta Casarrubios - Hospital Universitario Puerta de Hierro-Majadahonda, Madr...
Immune gene signatures for predicting response to neoadjuvant chemoimmunotherapy in NSCLC ( Dr Marta Casarrubios - Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain )
31 Mar 2022
ASCO GU 2022: Latest in mHSPC
Prof Eleni Efstathiou, Prof Karim Fizazi, Prof Kim Chi and Prof Matthew Smith
ASCO GU 2022: Latest in mHSPC ( Prof Eleni Efstathiou, Prof Karim Fizazi, Prof Kim Chi and Prof Matthew Smith )
8 Mar 2022
Atezolizumab with or without radiotherapy for advanced squamous cell carcinoma o...
Dr Hielke Martijn de Vries - Netherlands Cancer Institute, Amsterdam, The Nether...
Atezolizumab with or without radiotherapy for advanced squamous cell carcinoma of the penis ( Dr Hielke Martijn de Vries - Netherlands Cancer Institute, Amsterdam, The Netherlands )
24 Feb 2022
KEYNOTE 564 update: Pembrolizumab versus placebo as post-nephrectomy adjuvant th...
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
KEYNOTE 564 update: Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for patients with renal cell carcinoma ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
21 Feb 2022
Durvalumab with olapirib shows no PFS improvement for platinum-ineligible bladde...
Prof Jonathan Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA
Durvalumab with olapirib shows no PFS improvement for platinum-ineligible bladder cancer ( Prof Jonathan Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA )
21 Feb 2022
OncoAlert and ecancer weekly round up for February 7th - 13th, 2022
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly round up for February 7th - 13th, 2022 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
17 Feb 2022